HomeCompaniesProfile

Macromoltek

Computational antibody design 


Company Size

11 - 50 employees

Year Founded

2010


About Macromoltek

Macromoltek: Revolutionizing antibody design.

Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Founders & Key People

Monica Berrondo

Monica Berrondo

Founder/CEO, Macromoltek

Susana Kaufmann

Susana Kaufmann

Co-founder of Macromoltek

Share This Profile

More Companies

Humanly

We empower the world’s hiring teams to grow engaged, high-performing…

Bloom

Investing app that teaches you how to invest

Mason

Mason is the fastest way to take smart devices from idea to end user

Turing College

AI-driven online tech school for busy professionals

voize

We build the AI companion for nurses, to create time for care.

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.